Currus Biologics

Developer of CAR-T cell therapies for solid tumors

placeMelbourne, Victoria, Australia calendar_todayFounded 2020 groups5 employees language currusbio.com

Social engagement

Social engagement: 1.1K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Medical Research Commercialisation Fund.

Investor typeCountShare
Venture capital3100%

Recent activity

16 Jun 2026
Event
BIO International Convention
3 Jun 2026
Product launch
BEAT platform
Coming soon